

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 8.90010719 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.32563922 |
| 3 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.97821757 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.81040999 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 6.63208366 |
| 6 | regulation of B cell differentiation (GO:0045577) | 6.29297479 |
| 7 | response to interleukin-15 (GO:0070672) | 6.26250322 |
| 8 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 6.03528640 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.64967005 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.64967005 |
| 11 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 5.64635064 |
| 12 | * B cell proliferation (GO:0042100) | 5.46931548 |
| 13 | positive thymic T cell selection (GO:0045059) | 5.21198765 |
| 14 | mature B cell differentiation (GO:0002335) | 5.16691825 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.11961839 |
| 16 | regulation of antigen processing and presentation (GO:0002577) | 5.05940563 |
| 17 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 5.04274590 |
| 18 | cellular response to zinc ion (GO:0071294) | 5.01657503 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 4.99298931 |
| 20 | negative regulation of B cell proliferation (GO:0030889) | 4.95224968 |
| 21 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.87437087 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.78105559 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 4.75820502 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.73809699 |
| 25 | B cell mediated immunity (GO:0019724) | 4.67375005 |
| 26 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.66867823 |
| 27 | regulation of B cell proliferation (GO:0030888) | 4.66738145 |
| 28 | positive regulation of Rap GTPase activity (GO:0032854) | 4.65032111 |
| 29 | I-kappaB phosphorylation (GO:0007252) | 4.50290269 |
| 30 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.48315651 |
| 31 | regulation of interferon-alpha production (GO:0032647) | 4.42931967 |
| 32 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.31334431 |
| 33 | negative regulation of bone resorption (GO:0045779) | 4.31011943 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.30868693 |
| 35 | positive regulation of humoral immune response (GO:0002922) | 4.29947952 |
| 36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.28757295 |
| 37 | lymph node development (GO:0048535) | 4.26882464 |
| 38 | defense response to protozoan (GO:0042832) | 4.23697807 |
| 39 | negative regulation of histone methylation (GO:0031061) | 4.13784855 |
| 40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.06443520 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04011282 |
| 42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.01468347 |
| 43 | * B cell activation (GO:0042113) | 3.93126979 |
| 44 | regulation of Rap GTPase activity (GO:0032317) | 3.92278465 |
| 45 | regulation of B cell apoptotic process (GO:0002902) | 3.92238812 |
| 46 | detection of bacterium (GO:0016045) | 3.88491040 |
| 47 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.87098742 |
| 48 | positive regulation of B cell proliferation (GO:0030890) | 3.87052217 |
| 49 | thymic T cell selection (GO:0045061) | 3.86273618 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.82476303 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.82476303 |
| 52 | response to type I interferon (GO:0034340) | 3.81734632 |
| 53 | T cell migration (GO:0072678) | 3.75988773 |
| 54 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.72761344 |
| 55 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.72561938 |
| 56 | negative thymic T cell selection (GO:0045060) | 3.69864414 |
| 57 | B cell homeostasis (GO:0001782) | 3.69647208 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.67040452 |
| 59 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.65460222 |
| 60 | positive T cell selection (GO:0043368) | 3.64229807 |
| 61 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.61299556 |
| 62 | NIK/NF-kappaB signaling (GO:0038061) | 3.58059929 |
| 63 | positive regulation of interleukin-2 production (GO:0032743) | 3.57250966 |
| 64 | regulation of cellular extravasation (GO:0002691) | 3.56541221 |
| 65 | detection of other organism (GO:0098543) | 3.53061763 |
| 66 | T cell selection (GO:0045058) | 3.49664880 |
| 67 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.48280921 |
| 68 | negative regulation of bone remodeling (GO:0046851) | 3.48025456 |
| 69 | T cell lineage commitment (GO:0002360) | 3.47173960 |
| 70 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43358532 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 3.42855369 |
| 72 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.40936578 |
| 73 | positive regulation of neutrophil migration (GO:1902624) | 3.40936578 |
| 74 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.40207409 |
| 75 | response to protozoan (GO:0001562) | 3.39820700 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 3.39814536 |
| 77 | negative regulation of mast cell activation (GO:0033004) | 3.39486269 |
| 78 | negative regulation of cell killing (GO:0031342) | 3.39269093 |
| 79 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.39269093 |
| 80 | positive regulation of macrophage cytokine production (GO:0060907) | 3.37874853 |
| 81 | negative T cell selection (GO:0043383) | 3.35558524 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.33701203 |
| 83 | positive regulation of immunoglobulin production (GO:0002639) | 3.33577571 |
| 84 | lymphocyte homeostasis (GO:0002260) | 3.32392264 |
| 85 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.31656922 |
| 86 | regulation of B cell activation (GO:0050864) | 3.31376409 |
| 87 | myeloid dendritic cell activation (GO:0001773) | 3.29877816 |
| 88 | myeloid dendritic cell differentiation (GO:0043011) | 3.28787198 |
| 89 | cellular response to interferon-gamma (GO:0071346) | 3.27740021 |
| 90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.24840539 |
| 91 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.22958095 |
| 92 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.22400305 |
| 93 | positive regulation of B cell activation (GO:0050871) | 3.22066642 |
| 94 | cytidine metabolic process (GO:0046087) | 3.20428041 |
| 95 | cytidine catabolic process (GO:0006216) | 3.20428041 |
| 96 | cytidine deamination (GO:0009972) | 3.20428041 |
| 97 | negative regulation of B cell apoptotic process (GO:0002903) | 3.18419746 |
| 98 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.18215344 |
| 99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.17800369 |
| 100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.17800369 |
| 101 | modulation by symbiont of host immune response (GO:0052553) | 3.17800369 |
| 102 | positive regulation by symbiont of host defense response (GO:0052509) | 3.17800369 |
| 103 | modulation by symbiont of host defense response (GO:0052031) | 3.17800369 |
| 104 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.17800369 |
| 105 | antibacterial humoral response (GO:0019731) | 3.15931342 |
| 106 | respiratory burst (GO:0045730) | 3.15221617 |
| 107 | mature B cell differentiation involved in immune response (GO:0002313) | 3.14899298 |
| 108 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.14828054 |
| 109 | cellular response to exogenous dsRNA (GO:0071360) | 3.13455405 |
| 110 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.12227677 |
| 111 | positive regulation of interferon-beta production (GO:0032728) | 3.11999293 |
| 112 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.10477170 |
| 113 | regulation of histone H3-K27 methylation (GO:0061085) | 3.08567551 |
| 114 | locomotory exploration behavior (GO:0035641) | 3.08426432 |
| 115 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.05045101 |
| 116 | antimicrobial humoral response (GO:0019730) | 3.04048328 |
| 117 | * lymphocyte proliferation (GO:0046651) | 3.03024143 |
| 118 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.02774677 |
| 119 | T cell costimulation (GO:0031295) | 3.01877477 |
| 120 | neutrophil activation (GO:0042119) | 2.99843965 |
| 121 | * mononuclear cell proliferation (GO:0032943) | 2.99819853 |
| 122 | Peyers patch development (GO:0048541) | 2.99327382 |
| 123 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99327382 |
| 124 | histamine secretion (GO:0001821) | 2.98867619 |
| 125 | germinal center formation (GO:0002467) | 2.98722336 |
| 126 | positive regulation of interleukin-12 production (GO:0032735) | 2.98703370 |
| 127 | * immune response-activating signal transduction (GO:0002757) | 2.98508221 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 2.97893489 |
| 129 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.96316529 |
| 130 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.95607556 |
| 131 | lymphocyte costimulation (GO:0031294) | 2.94716582 |
| 132 | histone H3-K4 trimethylation (GO:0080182) | 2.94306303 |
| 133 | adaptive immune response (GO:0002250) | 2.91506539 |
| 134 | dendritic cell chemotaxis (GO:0002407) | 2.90564039 |
| 135 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90545431 |
| 136 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.88796677 |
| 137 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.88619827 |
| 138 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.86832914 |
| 139 | production of molecular mediator of immune response (GO:0002440) | 2.83983180 |
| 140 | response to interferon-gamma (GO:0034341) | 2.82670585 |
| 141 | B cell receptor signaling pathway (GO:0050853) | 10.3937760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.92792419 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.40327411 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.71297288 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.51921493 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.49405380 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.47837048 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.61317523 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58683993 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.29094635 |
| 10 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.24780191 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22656289 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13847278 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 3.00406968 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.68147876 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.61915993 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.52438906 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49854918 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.49166464 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47964307 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47332758 |
| 21 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.46300239 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.42379114 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.36239136 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34118762 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.33327205 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32637371 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27129712 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.26787021 |
| 29 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.14157941 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.12942933 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08665082 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.03565235 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.03464933 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02213317 |
| 35 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96291265 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93668545 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93588959 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90847061 |
| 39 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85353291 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78700978 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.77340246 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67105025 |
| 43 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66001572 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65287629 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63650181 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61604446 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60142793 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58931470 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.58586006 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50744572 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48909284 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45348905 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42495956 |
| 54 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39605398 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38399819 |
| 56 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.37295986 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30523290 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27894696 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25157428 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24790856 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.21086384 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18647980 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15644533 |
| 64 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.12111226 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10286579 |
| 66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10268139 |
| 67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09483229 |
| 68 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09406932 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09182027 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07564090 |
| 71 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03662807 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02743525 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00783631 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97686487 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96992992 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96579090 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96517531 |
| 78 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95642965 |
| 79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.94792012 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93108932 |
| 81 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92995939 |
| 82 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.90890216 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90289339 |
| 84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90272717 |
| 85 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89924977 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89884696 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86202580 |
| 88 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85071380 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84287510 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83802499 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83623774 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83599478 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83430218 |
| 94 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.83093309 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82118143 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82032157 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81687247 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81613545 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80277289 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79307757 |
| 101 | P300_27268052_Chip-Seq_Bcells_Human | 0.78846346 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78405107 |
| 103 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76708132 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76360854 |
| 105 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.74885688 |
| 106 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.74311909 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69974381 |
| 108 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.69593018 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69502628 |
| 110 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69347181 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68556144 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68448546 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66534130 |
| 114 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.66009019 |
| 115 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.65178997 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.65162603 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64605301 |
| 118 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.64536998 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63689659 |
| 120 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.61174583 |
| 121 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61081727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.58136954 |
| 2 | MP0001790_abnormal_immune_system | 5.60378708 |
| 3 | MP0005387_immune_system_phenotype | 5.60378708 |
| 4 | * MP0001800_abnormal_humoral_immune | 5.18729867 |
| 5 | MP0002452_abnormal_antigen_presenting | 3.93533968 |
| 6 | * MP0005000_abnormal_immune_tolerance | 3.59558846 |
| 7 | MP0002723_abnormal_immune_serum | 3.22149697 |
| 8 | * MP0002420_abnormal_adaptive_immunity | 3.09326037 |
| 9 | MP0003303_peritoneal_inflammation | 3.01245220 |
| 10 | * MP0000685_abnormal_immune_system | 3.00891597 |
| 11 | MP0001819_abnormal_immune_cell | 2.99872127 |
| 12 | * MP0002398_abnormal_bone_marrow | 2.79145434 |
| 13 | MP0005671_abnormal_response_to | 2.72802642 |
| 14 | MP0000716_abnormal_immune_system | 2.68763463 |
| 15 | MP0000689_abnormal_spleen_morphology | 2.67475177 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.44800544 |
| 17 | MP0001873_stomach_inflammation | 2.37581744 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.21749109 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.16401455 |
| 20 | MP0002429_abnormal_blood_cell | 2.13839400 |
| 21 | MP0009785_altered_susceptibility_to | 2.08933892 |
| 22 | MP0002419_abnormal_innate_immunity | 2.03650668 |
| 23 | MP0005025_abnormal_response_to | 2.02769571 |
| 24 | MP0002722_abnormal_immune_system | 2.02345720 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.96559642 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.96265230 |
| 27 | MP0002396_abnormal_hematopoietic_system | 1.94988709 |
| 28 | MP0005360_urolithiasis | 1.94978454 |
| 29 | MP0002405_respiratory_system_inflammati | 1.89792566 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.87997719 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.87120558 |
| 32 | MP0004510_myositis | 1.80473344 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.79093906 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.77742062 |
| 35 | MP0001853_heart_inflammation | 1.69266417 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.63465431 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.60679979 |
| 38 | MP0008260_abnormal_autophagy | 1.54554203 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.53534646 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.52775157 |
| 41 | MP0003724_increased_susceptibility_to | 1.47026870 |
| 42 | MP0003787_abnormal_imprinting | 1.44509842 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.43956555 |
| 44 | MP0000490_abnormal_crypts_of | 1.40687927 |
| 45 | MP0005310_abnormal_salivary_gland | 1.39639664 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.35616177 |
| 47 | MP0003091_abnormal_cell_migration | 1.30047873 |
| 48 | MP0002136_abnormal_kidney_physiology | 1.28354338 |
| 49 | MP0001666_abnormal_nutrient_absorption | 1.26535949 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.25902052 |
| 51 | MP0003436_decreased_susceptibility_to | 1.24536568 |
| 52 | MP0008874_decreased_physiological_sensi | 1.21230666 |
| 53 | MP0001348_abnormal_lacrimal_gland | 1.21224510 |
| 54 | MP0003866_abnormal_defecation | 1.19918436 |
| 55 | MP0002006_tumorigenesis | 1.19774344 |
| 56 | MP0003045_fibrosis | 1.15444081 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.13835381 |
| 58 | MP0004947_skin_inflammation | 1.13030757 |
| 59 | MP0002928_abnormal_bile_duct | 1.12045221 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.08837032 |
| 61 | MP0008469_abnormal_protein_level | 1.05560212 |
| 62 | MP0008057_abnormal_DNA_replication | 1.05270767 |
| 63 | MP0002009_preneoplasia | 1.02509161 |
| 64 | MP0003111_abnormal_nucleus_morphology | 0.99968553 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 0.99348608 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.94246474 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 0.91390037 |
| 68 | MP0009840_abnormal_foam_cell | 0.91105566 |
| 69 | MP0009764_decreased_sensitivity_to | 0.90318449 |
| 70 | MP0004381_abnormal_hair_follicle | 0.88485354 |
| 71 | MP0003252_abnormal_bile_duct | 0.87885788 |
| 72 | MP0000015_abnormal_ear_pigmentation | 0.87329168 |
| 73 | MP0002095_abnormal_skin_pigmentation | 0.86293105 |
| 74 | MP0010352_gastrointestinal_tract_polyps | 0.82270618 |
| 75 | MP0002933_joint_inflammation | 0.80866886 |
| 76 | MP0010307_abnormal_tumor_latency | 0.78952397 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 0.78037971 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.77719707 |
| 79 | MP0001879_abnormal_lymphatic_vessel | 0.77129513 |
| 80 | MP0000313_abnormal_cell_death | 0.74033452 |
| 81 | MP0000767_abnormal_smooth_muscle | 0.71341007 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.70333840 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.70186078 |
| 84 | MP0003868_abnormal_feces_composition | 0.69945448 |
| 85 | MP0003718_maternal_effect | 0.68852529 |
| 86 | MP0000858_altered_metastatic_potential | 0.68517918 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.68186059 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.64690473 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 0.64683792 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.63736083 |
| 91 | MP0000371_diluted_coat_color | 0.63653381 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 0.63317322 |
| 93 | MP0000249_abnormal_blood_vessel | 0.62520134 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.62040500 |
| 95 | MP0005451_abnormal_body_composition | 0.59232792 |
| 96 | MP0002254_reproductive_system_inflammat | 0.59203151 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.58789224 |
| 98 | MP0003690_abnormal_glial_cell | 0.57993726 |
| 99 | MP0000604_amyloidosis | 0.57519494 |
| 100 | MP0005621_abnormal_cell_physiology | 0.57341185 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.57241259 |
| 102 | MP0002163_abnormal_gland_morphology | 0.57061117 |
| 103 | MP0002168_other_aberrant_phenotype | 0.56773443 |
| 104 | MP0001730_embryonic_growth_arrest | 0.55066538 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.54711413 |
| 106 | MP0009763_increased_sensitivity_to | 0.54360317 |
| 107 | MP0001764_abnormal_homeostasis | 0.52435425 |
| 108 | * MP0005166_decreased_susceptibility_to | 0.52358104 |
| 109 | MP0005075_abnormal_melanosome_morpholog | 0.52182290 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.51478468 |
| 111 | MP0001663_abnormal_digestive_system | 0.49774959 |
| 112 | MP0002135_abnormal_kidney_morphology | 0.47136584 |
| 113 | MP0009115_abnormal_fat_cell | 0.46741738 |
| 114 | MP0001186_pigmentation_phenotype | 0.46226419 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.44883368 |
| 116 | MP0000609_abnormal_liver_physiology | 0.44802513 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.44697069 |
| 118 | MP0009643_abnormal_urine_homeostasis | 0.44159981 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43481293 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.42316749 |
| 121 | MP0000350_abnormal_cell_proliferation | 0.39945327 |
| 122 | MP0002083_premature_death | 0.36990556 |
| 123 | MP0005257_abnormal_intraocular_pressure | 0.36916284 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.36049776 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.35670518 |
| 126 | MP0003279_aneurysm | 0.34891475 |
| 127 | MP0001958_emphysema | 0.34800058 |
| 128 | MP0002075_abnormal_coat/hair_pigmentati | 0.34254307 |
| 129 | MP0008569_lethality_at_weaning | 0.33098640 |
| 130 | MP0005384_cellular_phenotype | 0.32870580 |
| 131 | MP0003077_abnormal_cell_cycle | 0.32187163 |
| 132 | MP0006082_CNS_inflammation | 0.31879492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.77501607 |
| 2 | * Gastrointestinal stroma tumor (HP:0100723) | 9.13703883 |
| 3 | Recurrent sinusitis (HP:0011108) | 6.92324951 |
| 4 | Recurrent bronchitis (HP:0002837) | 6.74016799 |
| 5 | Colitis (HP:0002583) | 6.31301164 |
| 6 | Cellulitis (HP:0100658) | 5.63716327 |
| 7 | * Emphysema (HP:0002097) | 5.41046804 |
| 8 | IgM deficiency (HP:0002850) | 5.30992140 |
| 9 | Inflammation of the large intestine (HP:0002037) | 5.30427096 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.15479587 |
| 11 | * Lymphopenia (HP:0001888) | 5.09329451 |
| 12 | Gastrointestinal inflammation (HP:0004386) | 5.01679915 |
| 13 | Recurrent viral infections (HP:0004429) | 4.95194157 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.86145270 |
| 15 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.78172010 |
| 16 | Chronic sinusitis (HP:0011109) | 4.70991654 |
| 17 | Verrucae (HP:0200043) | 4.69977778 |
| 18 | Papilloma (HP:0012740) | 4.69977778 |
| 19 | Meningitis (HP:0001287) | 4.35859951 |
| 20 | * Vasculitis (HP:0002633) | 4.22459716 |
| 21 | Chronic otitis media (HP:0000389) | 4.21719882 |
| 22 | Recurrent otitis media (HP:0000403) | 4.19294185 |
| 23 | * Restrictive lung disease (HP:0002091) | 4.18681813 |
| 24 | Recurrent pneumonia (HP:0006532) | 3.86833232 |
| 25 | Bronchitis (HP:0012387) | 3.81913381 |
| 26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.76982267 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 3.76978109 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.71233603 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.71233603 |
| 30 | Recurrent lower respiratory tract infections (HP:0002783) | 3.69409588 |
| 31 | Recurrent abscess formation (HP:0002722) | 3.64539452 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.52968524 |
| 33 | Osteomyelitis (HP:0002754) | 3.48782776 |
| 34 | Mitral stenosis (HP:0001718) | 3.47733390 |
| 35 | Abnormality of the fingertips (HP:0001211) | 3.32612803 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.29023145 |
| 37 | Papilledema (HP:0001085) | 3.25601310 |
| 38 | Recurrent skin infections (HP:0001581) | 3.23199839 |
| 39 | Viral hepatitis (HP:0006562) | 3.18849428 |
| 40 | Malnutrition (HP:0004395) | 3.05279852 |
| 41 | Increased IgM level (HP:0003496) | 3.02064815 |
| 42 | Small epiphyses (HP:0010585) | 2.96335578 |
| 43 | Sepsis (HP:0100806) | 2.95380117 |
| 44 | Abnormality of the prostate (HP:0008775) | 2.87768195 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.85973901 |
| 46 | Urticaria (HP:0001025) | 2.85863588 |
| 47 | * Leukopenia (HP:0001882) | 2.84726720 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.77133200 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.74970032 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.70401912 |
| 51 | * Lymphoma (HP:0002665) | 2.61469550 |
| 52 | Premature loss of primary teeth (HP:0006323) | 2.61232392 |
| 53 | Abnormality of T cells (HP:0002843) | 2.56298621 |
| 54 | Periodontitis (HP:0000704) | 2.47363951 |
| 55 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.42370739 |
| 56 | Resting tremor (HP:0002322) | 2.41784175 |
| 57 | * IgA deficiency (HP:0002720) | 2.38035303 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37663523 |
| 59 | Vertebral arch anomaly (HP:0008438) | 2.33068664 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.32125755 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.31908524 |
| 62 | B lymphocytopenia (HP:0010976) | 2.31908524 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.29114670 |
| 64 | Thrombocytosis (HP:0001894) | 2.27971452 |
| 65 | Fatigue (HP:0012378) | 2.27959277 |
| 66 | T lymphocytopenia (HP:0005403) | 2.26315100 |
| 67 | Encephalitis (HP:0002383) | 2.25513595 |
| 68 | Nasal polyposis (HP:0100582) | 2.25191968 |
| 69 | Skin ulcer (HP:0200042) | 2.24444329 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.24180321 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.23942264 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.23703179 |
| 73 | Obstructive lung disease (HP:0006536) | 2.22170922 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22170922 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.20886661 |
| 76 | Pustule (HP:0200039) | 2.19951641 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.16968388 |
| 78 | Granulocytopenia (HP:0001913) | 2.15894111 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.15386188 |
| 80 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.13660033 |
| 81 | Villous atrophy (HP:0011473) | 2.13660033 |
| 82 | Hypertensive crisis (HP:0100735) | 2.12717195 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09448651 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.09394824 |
| 85 | Xerostomia (HP:0000217) | 2.08196761 |
| 86 | * Arthralgia (HP:0002829) | 2.06104337 |
| 87 | Hematochezia (HP:0002573) | 2.05838211 |
| 88 | Myocardial infarction (HP:0001658) | 2.05176213 |
| 89 | IgG deficiency (HP:0004315) | 2.03555753 |
| 90 | Thyroiditis (HP:0100646) | 2.03467350 |
| 91 | Abnormality of male internal genitalia (HP:0000022) | 2.00699520 |
| 92 | Abnormality of the pleura (HP:0002103) | 2.00075894 |
| 93 | Acrocyanosis (HP:0001063) | 1.99848719 |
| 94 | Hypoplasia of the thymus (HP:0000778) | 1.98506167 |
| 95 | Skin rash (HP:0000988) | 1.97474762 |
| 96 | Macroorchidism (HP:0000053) | 1.96472819 |
| 97 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.95070689 |
| 98 | Flattened epiphyses (HP:0003071) | 1.94782120 |
| 99 | Hemoptysis (HP:0002105) | 1.94304414 |
| 100 | Pulmonary fibrosis (HP:0002206) | 1.94239398 |
| 101 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.90220620 |
| 102 | Absent epiphyses (HP:0010577) | 1.90220620 |
| 103 | Prostate neoplasm (HP:0100787) | 1.84851121 |
| 104 | Hepatitis (HP:0012115) | 1.84257951 |
| 105 | Ulnar bowing (HP:0003031) | 1.82900158 |
| 106 | Teleangiectasia of the skin (HP:0100585) | 1.82865341 |
| 107 | Spinal cord lesions (HP:0100561) | 1.82815382 |
| 108 | Syringomyelia (HP:0003396) | 1.82815382 |
| 109 | Spontaneous hematomas (HP:0007420) | 1.81883822 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 1.81183921 |
| 111 | Abnormality of the nasal mucosa (HP:0000433) | 1.79277359 |
| 112 | Chest pain (HP:0100749) | 1.78271796 |
| 113 | Increased IgE level (HP:0003212) | 1.77864608 |
| 114 | Irregular vertebral endplates (HP:0003301) | 1.76498817 |
| 115 | Eosinophilia (HP:0001880) | 1.75126002 |
| 116 | Absent frontal sinuses (HP:0002688) | 1.73332195 |
| 117 | Bronchiectasis (HP:0002110) | 1.72710457 |
| 118 | Petechiae (HP:0000967) | 1.72629677 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 1.69680990 |
| 120 | Facial diplegia (HP:0001349) | 1.68803755 |
| 121 | Amaurosis fugax (HP:0100576) | 1.67557198 |
| 122 | Neutropenia (HP:0001875) | 1.67344767 |
| 123 | Cerebral aneurysm (HP:0004944) | 1.61130238 |
| 124 | Arthropathy (HP:0003040) | 1.59802941 |
| 125 | Gingivitis (HP:0000230) | 1.57586641 |
| 126 | * Chronic diarrhea (HP:0002028) | 1.52188242 |
| 127 | Aqueductal stenosis (HP:0002410) | 1.51851258 |
| 128 | Gingival bleeding (HP:0000225) | 1.48779574 |
| 129 | Basal cell carcinoma (HP:0002671) | 1.47075297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.30601287 |
| 2 | MAP3K13 | 3.71397012 |
| 3 | PRPF4B | 3.68520306 |
| 4 | SMG1 | 3.11925562 |
| 5 | CSF1R | 3.11301258 |
| 6 | JAK1 | 3.08073539 |
| 7 | ERN1 | 2.99541226 |
| 8 | BTK | 2.75475248 |
| 9 | SIK2 | 2.71251262 |
| 10 | MAP3K14 | 2.67520058 |
| 11 | LRRK2 | 2.64983956 |
| 12 | GRK6 | 2.62149493 |
| 13 | GRK1 | 2.58196493 |
| 14 | BLK | 2.47085693 |
| 15 | SYK | 2.46858907 |
| 16 | RIPK4 | 2.22049969 |
| 17 | STK10 | 2.21239380 |
| 18 | TYK2 | 2.10164851 |
| 19 | FRK | 1.79754515 |
| 20 | CDK12 | 1.79547069 |
| 21 | IRAK3 | 1.69761218 |
| 22 | PASK | 1.67677218 |
| 23 | CSK | 1.67291132 |
| 24 | SIK3 | 1.61867615 |
| 25 | LYN | 1.60644478 |
| 26 | NEK9 | 1.60257877 |
| 27 | HCK | 1.57557913 |
| 28 | MARK3 | 1.46161326 |
| 29 | KIT | 1.41851418 |
| 30 | VRK1 | 1.40112828 |
| 31 | MAP3K10 | 1.39849701 |
| 32 | TAF1 | 1.38172643 |
| 33 | BRD4 | 1.35110675 |
| 34 | JAK3 | 1.32803159 |
| 35 | MATK | 1.29980994 |
| 36 | IRAK4 | 1.28331546 |
| 37 | STK24 | 1.25542649 |
| 38 | MST4 | 1.24449259 |
| 39 | CDC42BPA | 1.20709503 |
| 40 | IKBKB | 1.19617801 |
| 41 | TGFBR2 | 1.14031956 |
| 42 | SIK1 | 1.12089968 |
| 43 | TLK1 | 1.11475907 |
| 44 | MAP3K9 | 1.07738308 |
| 45 | PRKCQ | 1.04206443 |
| 46 | ITK | 1.02616899 |
| 47 | LCK | 1.00622591 |
| 48 | CDK19 | 0.98528441 |
| 49 | FES | 0.96586356 |
| 50 | NLK | 0.96421323 |
| 51 | MAPK11 | 0.96089292 |
| 52 | TBK1 | 0.94931356 |
| 53 | ACVR1B | 0.93661869 |
| 54 | VRK2 | 0.93138209 |
| 55 | TEC | 0.93006671 |
| 56 | ALK | 0.91415215 |
| 57 | CLK1 | 0.84525480 |
| 58 | PRKCH | 0.81163903 |
| 59 | FGFR3 | 0.80040199 |
| 60 | ABL1 | 0.79963002 |
| 61 | FGFR4 | 0.79411763 |
| 62 | TNK2 | 0.79153989 |
| 63 | FGR | 0.77996008 |
| 64 | IKBKE | 0.77562363 |
| 65 | CAMK1G | 0.77069339 |
| 66 | EEF2K | 0.76445606 |
| 67 | ZAP70 | 0.74820423 |
| 68 | WNK1 | 0.74606086 |
| 69 | TRIB3 | 0.72865521 |
| 70 | CSNK1A1L | 0.72030192 |
| 71 | CHUK | 0.71694897 |
| 72 | HIPK2 | 0.70416115 |
| 73 | MAP3K7 | 0.63627364 |
| 74 | INSR | 0.63256246 |
| 75 | MAP3K8 | 0.62862312 |
| 76 | TESK2 | 0.62655472 |
| 77 | CDC7 | 0.60447706 |
| 78 | PDK1 | 0.60257143 |
| 79 | DAPK3 | 0.60145959 |
| 80 | PRKD2 | 0.56938841 |
| 81 | RPS6KA5 | 0.55192171 |
| 82 | CAMK1D | 0.54079025 |
| 83 | FYN | 0.53050639 |
| 84 | MAPK7 | 0.52907787 |
| 85 | ARAF | 0.50403757 |
| 86 | TAOK3 | 0.50365551 |
| 87 | KDR | 0.49465961 |
| 88 | ZAK | 0.48862860 |
| 89 | PIM1 | 0.47717064 |
| 90 | PTK6 | 0.47439842 |
| 91 | CDK9 | 0.45697898 |
| 92 | BMPR2 | 0.44487881 |
| 93 | STK4 | 0.43698971 |
| 94 | PRKD1 | 0.43652191 |
| 95 | JAK2 | 0.42485289 |
| 96 | ERBB3 | 0.41919528 |
| 97 | MAP3K1 | 0.41852296 |
| 98 | TXK | 0.39289190 |
| 99 | EGFR | 0.38805894 |
| 100 | BRAF | 0.38796316 |
| 101 | MAPK4 | 0.37790610 |
| 102 | PRKCI | 0.37337363 |
| 103 | SGK3 | 0.37133257 |
| 104 | IRAK1 | 0.35183616 |
| 105 | EIF2AK3 | 0.34920648 |
| 106 | MAPK12 | 0.33707953 |
| 107 | CDK4 | 0.32798456 |
| 108 | EPHB1 | 0.32633376 |
| 109 | MAPKAPK2 | 0.31866162 |
| 110 | CSNK1A1 | 0.30609278 |
| 111 | RPS6KA4 | 0.30124932 |
| 112 | CDK7 | 0.28357208 |
| 113 | CCNB1 | 0.27845405 |
| 114 | EPHA3 | 0.27785238 |
| 115 | TTN | 0.26450538 |
| 116 | CSNK1G3 | 0.25798341 |
| 117 | CSNK1G1 | 0.25522852 |
| 118 | CHEK1 | 0.25256120 |
| 119 | IGF1R | 0.23454734 |
| 120 | PKN1 | 0.23060793 |
| 121 | MAP2K1 | 0.23055251 |
| 122 | MARK2 | 0.21868178 |
| 123 | YES1 | 0.20881802 |
| 124 | CSNK1G2 | 0.20682884 |
| 125 | DYRK1A | 0.20631487 |
| 126 | DYRK1B | 0.20361902 |
| 127 | SRC | 0.17752222 |
| 128 | STK11 | 0.17541987 |
| 129 | CSNK1D | 0.17038566 |
| 130 | MELK | 0.16795173 |
| 131 | PRKCD | 0.16474255 |
| 132 | KSR2 | 0.15914960 |
| 133 | PRKAA2 | 0.15682404 |
| 134 | PDPK1 | 0.15533706 |
| 135 | CDK6 | 0.14382381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.88262453 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.49437855 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.63709731 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.38588523 |
| 5 | Asthma_Homo sapiens_hsa05310 | 4.29757999 |
| 6 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 4.23619056 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.03967979 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.53967927 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.18599038 |
| 10 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.85901990 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35026820 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27550691 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.07479129 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98706589 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.96797902 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93391651 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87399613 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.76183256 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63799922 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61847989 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56653168 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.53521297 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46546317 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44397406 |
| 25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41705453 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40928111 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36640623 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.36095156 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.34424786 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.25868275 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24182713 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20390252 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 1.17685948 |
| 34 | Alcoholism_Homo sapiens_hsa05034 | 1.14788089 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12186409 |
| 36 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08991300 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07725831 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.05803986 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.05327546 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04267718 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.03968723 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01861941 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01584686 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.99250437 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98053131 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96889519 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.96006011 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.95656238 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.94390440 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91461384 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88068028 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85437099 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78415956 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78004133 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75706481 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74415949 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73606545 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71949878 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.70505197 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68313196 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66146624 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63506207 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62977090 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62372611 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61379443 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60890437 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60226247 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60090069 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59646002 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58269794 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.57680607 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57569656 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57053318 |
| 74 | DNA replication_Homo sapiens_hsa03030 | 0.52649554 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52645459 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52234910 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52179384 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50006897 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49966768 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.49892773 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48204164 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.46137502 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.45636568 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45087875 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43850821 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.43208436 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.43167381 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42485892 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42043708 |
| 90 | Long-term depression_Homo sapiens_hsa04730 | 0.41136454 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40515944 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38280971 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38085022 |
| 94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37654913 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.37589557 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.37524379 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.36897175 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36873236 |
| 99 | Mismatch repair_Homo sapiens_hsa03430 | 0.36430258 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.35473483 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35237315 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34605540 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34427865 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34195406 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32731883 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32617872 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31432536 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30535734 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29729357 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29544445 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27761166 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.27735773 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27341167 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26187708 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25742817 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25647347 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.25374994 |
| 118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23266763 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.22377516 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22333433 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19786989 |
| 122 | Cell cycle_Homo sapiens_hsa04110 | 0.19766366 |
| 123 | Homologous recombination_Homo sapiens_hsa03440 | 0.18700886 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17431853 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16404771 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16193654 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15196059 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.13534131 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10968180 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.10068584 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09724057 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.08570376 |
| 133 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.07784311 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.05962984 |
| 135 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.05609249 |
| 136 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.05399530 |
| 137 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.05326322 |
| 138 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.05271995 |

